Despite its successes, PREA faces several challenges. Conducting pediatric studies can be difficult due to ethical considerations, recruitment challenges, and the need for age-appropriate formulations. Additionally, some critics argue that the timelines for completing pediatric studies can be lengthy, delaying access to new treatments for children.
